ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 41 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,079,000 | +25.8% | 5,569,000 | +19.4% | 0.23% | +2.2% |
| Q3 2020 | $4,831,000 | -12.2% | 4,663,000 | -6.7% | 0.23% | -26.9% |
| Q2 2020 | $5,503,000 | -28.0% | 5,000,000 | -33.3% | 0.31% | -48.3% |
| Q1 2020 | $7,639,000 | -16.6% | 7,500,000 | -6.2% | 0.60% | +18.9% |
| Q4 2019 | $9,158,000 | +779.7% | 8,000,000 | +813.2% | 0.51% | +745.0% |
| Q2 2019 | $1,041,000 | -91.8% | 876,000 | -90.7% | 0.06% | -92.1% |
| Q1 2019 | $12,676,000 | +100.7% | 9,376,000 | +59.6% | 0.76% | +79.9% |
| Q4 2018 | $6,316,000 | +584.3% | 5,876,000 | +570.8% | 0.42% | +984.6% |
| Q3 2018 | $923,000 | -32.5% | 876,000 | -37.2% | 0.04% | -39.1% |
| Q2 2018 | $1,367,000 | -59.2% | 1,396,000 | -58.8% | 0.06% | -61.7% |
| Q1 2018 | $3,350,000 | -6.7% | 3,388,000 | 0.0% | 0.17% | -5.6% |
| Q4 2017 | $3,589,000 | +89.5% | 3,388,000 | +89.5% | 0.18% | +90.3% |
| Q3 2017 | $1,894,000 | -78.5% | 1,788,000 | -78.4% | 0.09% | -78.3% |
| Q2 2017 | $8,811,000 | +411.4% | 8,288,000 | +363.5% | 0.43% | +315.5% |
| Q1 2017 | $1,723,000 | -93.0% | 1,788,000 | -92.7% | 0.10% | -92.4% |
| Q4 2016 | $24,787,000 | +758.6% | 24,383,000 | +494.7% | 1.35% | +601.0% |
| Q2 2016 | $2,887,000 | +85.7% | 4,100,000 | +139.8% | 0.19% | +101.0% |
| Q1 2016 | $1,555,000 | -87.7% | 1,710,000 | -84.7% | 0.10% | -87.2% |
| Q4 2015 | $12,623,000 | – | 11,210,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|